Related Experiment Video
Updated: May 28, 2026
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Intense suicidal thoughts and self-harm following escitalopram treatment
1Department of Older Adults Psychiatry, South Staffordshire and Shropshire NHS Foundation Trust and Staffordshire University, UK.
Indian Journal of Psychological Medicine
|October 25, 2011
Summary
Antidepressant treatment can trigger suicidal thoughts in some patients. This case study highlights the risk associated with escitalopram, emphasizing the need for patient and family awareness and prompt medical attention.
Area of Science:
- Psychiatry
- Clinical Pharmacology
- Neuroscience
Background:
- Antidepressant medications are a cornerstone in treating major depressive disorder.
- Selective Serotonin Reuptake Inhibitors (SSRIs) are commonly prescribed, but carry potential risks.
- A subset of patients may experience paradoxical adverse effects from antidepressants.
Observation:
- A 52-year-old woman developed intense suicidal ideation and behaviors upon treatment with escitalopram.
- This adverse event was specific to escitalopram, a SSRI.
- No similar reactions occurred when the patient was treated with six other non-SSRI antidepressants.
Findings:
- Escitalopram, an SSRI, can induce severe suicidal thoughts and actions in vulnerable individuals.
- The patient's history suggests a specific sensitivity to SSRIs rather than antidepressants generally.
- Non-SSRI antidepressants did not elicit the same adverse effect profile.
Implications:
- Healthcare providers must counsel patients and families about the potential for antidepressant-induced suicidal ideation.
- Vigilant monitoring for emergent suicidal behaviors is crucial when initiating antidepressant therapy.
- Early recognition and intervention are vital to mitigate risks associated with antidepressant treatment.
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...